| Product Name | CALML5 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CALML5 antibody; CLSP antibody; Calmodulin-like protein 5 antibody; Calmodulin-like skin protein antibody; |
| Product description | This gene encodes a novel calcium binding protein expressed in the epidermis and related to the calmodulin family of calcium binding proteins. Functional studies with recombinant protein demonstrate it does bind calcium and undergoes a conformational change when it does so. Abundant expression is detected only in reconstructed epidermis and is restricted to differentiating keratinocytes. In addition, it can associate with transglutaminase 3, shown to be a key enzyme in the terminal differentiation of keratinocytes. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human CALML5. AA range:96-146 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC |
| IHC:1:100-1:300 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | CALML5 antibody CLSP antibody Calmodulin-like protein 5 antibody Calmodulin-like skin protein antibody |
|---|---|
| Molecular Weight(MW) | kDa |
| SwissProt ID | Q9NZT1 |
|---|
| Positive Control | Dermoid cancer,Hepatoma,Skin, |
|---|---|
| Application Notes | IHC:1:100-1:300 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
